NDC 55494-120 – Bonjesta

Doxylamine Succinate 20 mg/1; Pyridoxine Hydrochloride 20 mg/1 · Tablet, Extended Release · Oral

Human Prescription Drug

Product NDC55494-120

Product details

Brand name
Bonjesta
Generic name
Doxylamine succinate and pyridoxine hydrochloride
Labeler
Duchesnay USA, Inc.
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
NDA · NDA209661
Marketed since
February 19, 2018
Listing expires
December 31, 2026
Pharmacologic class
Antihistamine; Vitamin B6 Analog

Active ingredients

Uses, dosage, side effects and warnings for Bonjesta →

Package NDC codes (4)

Package NDCDescriptionSince
55494-120-10100 TABLET, EXTENDED RELEASE in 1 BOTTLE (55494-120-10)Feb 19, 2018
55494-120-6060 TABLET, EXTENDED RELEASE in 1 BOTTLE (55494-120-60)Feb 19, 2018
55494-120-94 sample1 BLISTER PACK in 1 CARTON (55494-120-94) / 4 TABLET, EXTENDED RELEASE in 1 BLISTER PACKFeb 26, 2025
55494-120-99 sample6 TABLET, EXTENDED RELEASE in 1 BOTTLE (55494-120-99)Feb 19, 2018